AI brief of an SEC Form 8-K · IDEX (IEX)
IDEX raises 2026 guidance as third-quarter record sales rise 8% to $952 million
IDEX reported record third-quarter 2026 net sales of $952 million, up 8% from a year earlier, and diluted EPS of $1.95, up 15%. The company raised its full-year 2026 guidance for organic sales growth and adjusted diluted EPS, which gives shareholders a higher outlook for the year.
Key points
- Q3 net sales of $951.7 million rose 8%; organic sales also rose 8%, with orders up 13% to $991.2 million
- Diluted EPS attributable to IDEX was $1.95 versus $1.70; adjusted diluted EPS was $2.33 versus $2.03, up 15%
- Full-year adjusted diluted EPS guidance raised to $8.91 to $8.96 from $8.70 to $8.85
- Full-year organic sales growth guidance raised to 6.5% to 6.8% from 5% to 6%
The filing
CompanyIDEX (IEX)
Form8-K, current report
Filed with the SECOct 28, 2026, 7:01 AM ET
Accession number0000832101-26-000026
Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.